...
首页> 外文期刊>Journal of Medicinal Chemistry >Design, synthesis, and enzymatic evaluation of multisubstrate analogue inhibitors of Escherichia coli thymidine phosphorylase.
【24h】

Design, synthesis, and enzymatic evaluation of multisubstrate analogue inhibitors of Escherichia coli thymidine phosphorylase.

机译:大肠杆菌胸苷磷酸化酶的多底物类似物抑制剂的设计,合成和酶促评估。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of acyclic phosphonate derivatives of thymine has been synthesized and tested as multisubstrate analogue inhibitors of Escherichia coli thymidine phosphorylase. The compounds synthesized include 1-(phosphonoalkyl)thymines with six to nine methylenes (1-4, respectively); 1-[(Z)-4-phosphonomethoxy-2-butenyl]thymine (5) and its butyl and 2,3-cis-dihydroxybutyl derivatives (6 and 7, respectively); 1-[(Z)-(4-(phosphonomethoxy)methoxy)-2-butenyl]thymine (8) and also its butyl and 2,3-cis-dihydroxybutyl analogues (9 and 10); and 1-[((Z)-4-(phosphonomethoxy)-2-butenoxy)methyl]thymine (11). Evaluation of these compounds against E. coli revealed significant enzymatic inhibition by 2, 3, 4, 6, and 8 at a concentration of 1000 microM, 3 and 4 being the most potent. Replacement of the thymine base in 3 by 6-amino-5-bromouracil and 7-deazaxanthine afforded compounds 12 and 13, which showed a pronounced improvement of TPase inhibition, comparable to 7-deazaxanthine. When inorganic phosphate was used as a variable substrate, compounds 12 and 13 displayed competitive kinetics with respect to phosphate, indicating a direct interaction of these compounds with the phosphate binding site. Also compounds 12 and 13 were found to be competitive inhibitors of TPase against thymidine as a variable substrate. These results are consistent with the compounds being multisubstrate analogue inhibitors of E. coli TPase, and they represent the first example of such TPase inhibitors.
机译:已合成了一系列胸腺嘧啶的无环膦酸酯衍生物,并已作为大肠杆菌胸苷磷酸化酶的多底物类似物抑制剂进行了测试。合成的化合物包括1-(膦酰基烷基)胸腺嘧啶,具有六个至九个亚甲基(分别为1-4); 1-[(Z)-4-膦酰基甲氧基-2-丁烯基]胸腺嘧啶(5)及其丁基和2,3-顺-二羟基丁基衍生物(分别为6和7); 1-[(Z)-(4-(膦酰基甲氧基)甲氧基)-2-丁烯基]胸腺嘧啶(8),以及其丁基和2,3-顺式-二羟基丁基类似物(9和10);和1-[((Z)-4-(膦甲氧基)-2-丁烯氧基)甲基]胸腺嘧啶(11)。这些化合物对大肠杆菌的评估表明,浓度为1000 microM时,酶2、3、4、6和8具有明显的酶抑制作用,其中3和4是最有效的。用6-氨基-5-溴尿嘧啶和7-脱氮黄嘌呤取代3中的胸腺嘧啶碱基,得到化合物12和13,与7-脱氮黄嘌呤相比,TPase抑制作用明显改善。当无机磷酸盐用作可变底物时,化合物12和13相对于磷酸盐显示出竞争动力学,表明这些化合物与磷酸盐结合位点直接相互作用。还发现化合物12和13是TPase相对于作为可变底物的胸苷的竞争性抑制剂。这些结果与该化合物是大肠杆菌TPase的多底物类似物抑制剂是一致的,它们代表了这种TPase抑制剂的第一个实例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号